Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 2
1955 1
1957 1
1961 2
1962 1
1963 1
1964 2
1965 3
1966 3
1967 1
1968 2
1969 4
1971 1
1972 2
1974 4
1975 6
1976 2
1977 2
1978 11
1979 11
1980 10
1981 3
1982 12
1983 9
1984 14
1985 8
1986 8
1987 14
1988 18
1989 18
1990 25
1991 15
1992 25
1993 19
1994 19
1995 16
1996 20
1997 10
1998 17
1999 7
2000 11
2001 17
2002 14
2003 26
2004 17
2005 24
2006 25
2007 21
2008 35
2009 42
2010 34
2011 34
2012 31
2013 29
2014 27
2015 43
2016 49
2017 28
2018 27
2019 27
2020 40
2021 45
2022 81
2023 96
2024 47

Text availability

Article attribute

Article type

Publication date

Search Results

1,104 results

Results by year

Filters applied: . Clear all
Page 1
Androgen Receptor Signaling Inhibitors in Addition to Docetaxel with Androgen Deprivation Therapy for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysis.
Yanagisawa T, Rajwa P, Thibault C, Gandaglia G, Mori K, Kawada T, Fukuokaya W, Shim SR, Mostafaei H, Motlagh RS, Quhal F, Laukhtina E, Pallauf M, Pradere B, Kimura T, Egawa S, Shariat SF. Yanagisawa T, et al. Eur Urol. 2022 Dec;82(6):584-598. doi: 10.1016/j.eururo.2022.08.002. Epub 2022 Aug 19. Eur Urol. 2022. PMID: 35995644 Free article. Review.
The future potential of the Stentrode.
John SE, Grayden DB, Yanagisawa T. John SE, et al. Among authors: yanagisawa t. Expert Rev Med Devices. 2019 Oct;16(10):841-843. doi: 10.1080/17434440.2019.1674139. Epub 2019 Oct 9. Expert Rev Med Devices. 2019. PMID: 31568731 No abstract available.
Real-world survival outcome comparing abiraterone acetate plus prednisone and enzalutamide for nonmetastatic castration-resistant prostate cancer.
Tsujino T, Tokushige S, Komura K, Fukuokaya W, Adachi T, Hirasawa Y, Hashimoto T, Yoshizawa A, Saruta M, Ohno T, Nakamori K, Maenosono R, Nishimura K, Yamazaki S, Uchimoto T, Yanagisawa T, Mori K, Urabe F, Tsuzuki S, Iwatani K, Yamamoto S, Takahara K, Inamoto T, Kimura T, Ohno Y, Shiroki R, Azuma H. Tsujino T, et al. Among authors: yanagisawa t. Cancer Med. 2023 Oct;12(19):19414-19422. doi: 10.1002/cam4.6536. Epub 2023 Sep 14. Cancer Med. 2023. PMID: 37706578 Free PMC article.
The Efficacy and Safety of Metastasis-directed Therapy in Patients with Prostate Cancer: A Systematic Review and Meta-analysis of Prospective Studies.
Miszczyk M, Rajwa P, Yanagisawa T, Nowicka Z, Shim SR, Laukhtina E, Kawada T, von Deimling M, Pradere B, Rivas JG, Gandaglia G, van den Bergh RCN, Goldner G, Supiot S, Zilli T, Trinh QD, Nguyen PL, Briganti A, Ost P, Ploussard G, Shariat SF. Miszczyk M, et al. Among authors: yanagisawa t. Eur Urol. 2024 Feb;85(2):125-138. doi: 10.1016/j.eururo.2023.10.012. Epub 2023 Nov 7. Eur Urol. 2024. PMID: 37945451 Free article. Review.
Efficacy of Systemic Treatment in Prostate Cancer Patients With Visceral Metastasis: A Systematic Review, Meta-analysis, and Network Meta-analysis.
Yanagisawa T, Rajwa P, Kawada T, Mori K, Fukuokaya W, Petrov P, Quhal F, Laukhtina E, von Deimling M, Bianchi A, Majdoub M, Pradere B, Kramer G, Kimura T, Shariat SF. Yanagisawa T, et al. J Urol. 2023 Sep;210(3):416-429. doi: 10.1097/JU.0000000000003594. Epub 2023 Jun 20. J Urol. 2023. PMID: 37339479 Review.
Iatrogenic ureteric injury during abdominal or pelvic surgery: a meta-analysis.
Yanagisawa T, Mori K, Quhal F, Kawada T, Mostafaei H, Laukhtina E, Rajwa P, Sari Motlagh R, Aydh A, König F, Pallauf M, Pradere B, Miki J, Kimura T, Egawa S, Shariat SF. Yanagisawa T, et al. BJU Int. 2023 May;131(5):540-552. doi: 10.1111/bju.15913. Epub 2022 Oct 18. BJU Int. 2023. PMID: 36196670 Review.
Differential efficacy of ablation therapy versus partial nephrectomy between clinical T1a and T1b renal tumors: A systematic review and meta-analysis.
Yanagisawa T, Mori K, Kawada T, Motlagh RS, Mostafaei H, Quhal F, Laukhtina E, Rajwa P, Aydh A, König F, Pallauf M, Pradere B, Miki J, Kimura T, Egawa S, Shariat SF. Yanagisawa T, et al. Urol Oncol. 2022 Jul;40(7):315-330. doi: 10.1016/j.urolonc.2022.04.002. Epub 2022 May 11. Urol Oncol. 2022. PMID: 35562311 Free article. Review.
A Systematic Review and Meta-analysis of Chemoablation for Non-muscle-invasive Bladder Cancer.
Yanagisawa T, Quhal F, Kawada T, Mostafaei H, Motlagh RS, Laukhtina E, Rajwa P, Deimling MV, Bianchi A, Pallauf M, Majdoub M, Pradere B, Moschini M, Karakiewicz PI, Teoh JY, Miki J, Kimura T, Shariat SF. Yanagisawa T, et al. Eur Urol Focus. 2023 May;9(3):463-479. doi: 10.1016/j.euf.2022.12.003. Epub 2022 Dec 12. Eur Urol Focus. 2023. PMID: 36517409 Free article. Review.
1,104 results